CIBC World Markets’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $19.7M | Buy |
+790,917
| New | +$19.9M | 0.09% | 149 |
|
|
2025
Q2 | $17.3M | Buy |
714,862
+31,310
| +5% | +$730K | 0.11% | 154 |
|
|
2025
Q1 | $17.3M | Sell |
683,552
-218,690
| -24% | -$5.72M | 0.14% | 113 |
|
|
2024
Q4 | $23.9M | Buy |
902,242
+133,084
| +17% | +$3.61M | 0.14% | 113 |
|
|
2024
Q3 | $22.3M | Sell |
769,158
-320,163
| -29% | -$9.34M | 0.16% | 101 |
|
|
2024
Q2 | $30.5M | Buy |
1,089,321
+510,271
| +88% | +$14M | 0.2% | 83 |
|
|
2024
Q1 | $16.1M | Sell |
579,050
-657,282
| -53% | -$18.2M | 0.11% | 138 |
|
|
2023
Q4 | $35.6M | Buy |
1,236,332
+924,710
| +297% | +$28M | 0.19% | 85 |
|
|
2023
Q3 | $10.3M | Sell |
311,622
-349,971
| -53% | -$12.4M | 0.1% | 150 |
|
|
2023
Q2 | $24.3M | Buy |
661,593
+190,699
| +40% | +$7.42M | 0.2% | 85 |
|
|
2023
Q1 | $19.2M | Sell |
470,894
-247,137
| -34% | -$10.7M | 0.31% | 67 |
|
|
2022
Q4 | $36.8M | Buy |
718,031
+632,872
| +743% | +$30.3M | 0.25% | 67 |
|
|
2022
Q3 | $3.73M | Sell |
85,159
-306,538
| -78% | -$14.9M | 0.05% | 183 |
|
|
2022
Q2 | $20.5M | Sell |
391,697
-1,263,002
| -76% | -$64.4M | 0.19% | 67 |
|
|
2022
Q1 | $85.7M | Buy |
1,654,699
+196,148
| +13% | +$10.2M | 0.67% | 31 |
|
|
2021
Q4 | $86.1M | Buy |
1,458,551
+91,750
| +7% | +$4.55M | 0.46% | 41 |
|
|
2021
Q3 | $58.8M | Buy |
1,366,801
+978,142
| +252% | +$43.3M | 0.4% | 43 |
|
|
2021
Q2 | $15.2M | Sell |
388,659
-143,085
| -27% | -$5.56M | 0.11% | 122 |
|
|
2021
Q1 | $19.3M | Sell |
531,744
-930,719
| -64% | -$33M | 0.12% | 133 |
|
|
2020
Q4 | $53.8M | Buy |
1,462,463
+757,121
| +107% | +$27.8M | 0.27% | 77 |
|
|
2020
Q3 | $24.6M | Buy |
705,342
+118,649
| +20% | +$4.16M | 0.24% | 99 |
|
|
2020
Q2 | $18.2M | Sell |
586,693
-32,419
| -5% | -$1.1M | 0.2% | 109 |
|
|
2020
Q1 | $19.2M | Sell |
619,112
-644,492
| -51% | -$22M | 0.24% | 94 |
|
|
2019
Q4 | $47M | Sell |
1,263,604
-998,720
| -44% | -$35.6M | 0.3% | 79 |
|
|
2019
Q3 | $77.1M | Buy |
2,262,324
+777,820
| +52% | +$28.3M | 0.72% | 28 |
|
|
2019
Q2 | $61M | Sell |
1,484,504
-47,676
| -3% | -$1.89M | 0.47% | 48 |
|
|
2019
Q1 | $61.7M | Sell |
1,532,180
-1,016,644
| -40% | -$40.7M | 0.51% | 43 |
|
|
2018
Q4 | $106M | Buy |
2,548,824
+691,121
| +37% | +$28.7M | 0.98% | 19 |
|
|
2018
Q3 | $77.7M | Sell |
1,857,703
-1,217,771
| -40% | -$46.9M | 0.66% | 27 |
|
|
2018
Q2 | $106M | Buy |
3,075,474
+192,639
| +7% | +$6.58M | 0.91% | 19 |
|
|
2018
Q1 | $97.1M | Sell |
2,882,835
-2,722,369
| -49% | -$93.6M | 1.03% | 13 |
|
|
2017
Q4 | $193M | Buy |
5,605,204
+140,915
| +3% | +$4.8M | 1.38% | 9 |
|
|
2017
Q3 | $185M | Buy |
5,464,289
+4,206,872
| +335% | +$135M | 1.78% | 6 |
|
|
2017
Q2 | $40.1M | Sell |
1,257,417
-11,657,416
| -90% | -$368M | 0.42% | 53 |
|
|
2017
Q1 | $419M | Buy |
12,914,833
+10,634,719
| +466% | +$335M | 3.41% | 4 |
|
|
2016
Q4 | $70.3M | Sell |
2,280,114
-632,821
| -22% | -$19.3M | 0.72% | 26 |
|
|
2016
Q3 | $93.6M | Buy |
2,912,935
+2,805,909
| +2,622% | +$93.8M | 1.78% | 12 |
|
|
2016
Q2 | $3.58M | Buy |
107,026
+98,813
| +1,203% | +$3.15M | 0.09% | 112 |
|
|
2016
Q1 | $231K | Sell |
8,213
-44,613
| -84% | -$1.27M | 0.01% | 223 |
|
|
2015
Q4 | $1.62M | Sell |
52,826
-2,621,048
| -98% | -$82.5M | 0.03% | 185 |
|
|
2015
Q3 | $79.7M | Buy |
2,673,874
+2,528,076
| +1,734% | +$81.1M | 2.15% | 9 |
|
|
2015
Q2 | $4.64M | Buy |
+145,798
| New | +$4.75M | 0.15% | 84 |
|
Other funds holding PFE
CIBC World Markets's PFE Position: Q4 2025 in Review
CIBC World Markets opened a new position in Pfizer (PFE) in Q4 2025: 790,917 shares worth $19.7M. The stake represents 0.09% of the portfolio and ranks #149 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in PFE as recently as Q2 2025.
CIBC World Markets first reported a position in PFE in Q2 2015 and has held it in 42 quarters since. The position peaked at $419M in Q1 2017. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- CIBC World Markets held 790,917 shares of Pfizer worth $19.7M as of Q4 2025.
- Pfizer was a new CIBC World Markets position in Q4 2025.
- Pfizer made up 0.09% of CIBC World Markets's portfolio in Q4 2025, its #149 holding.
- CIBC World Markets first reported a position in Pfizer in Q2 2015 and has held it in 42 quarters since.
- CIBC World Markets's Pfizer position peaked at $419M in Q1 2017.
- 2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.